BIONDVAX PHARMACEUTICALS LTD's ticker is BVXV and the CUSIP is 09073Q105. A total of 13 filers reported holding BIONDVAX PHARMACEUTICALS LTD in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $3,000 | -40.0% | 4,240 | 0.0% | 0.00% | – |
| Q2 2022 | $5,000 | -28.6% | 4,240 | 0.0% | 0.00% | – |
| Q1 2022 | $7,000 | -30.0% | 4,240 | 0.0% | 0.00% | – |
| Q4 2021 | $10,000 | +11.1% | 4,240 | 0.0% | 0.00% | – |
| Q3 2021 | $9,000 | -25.0% | 4,240 | 0.0% | 0.00% | – |
| Q2 2021 | $12,000 | -25.0% | 4,240 | 0.0% | 0.00% | – |
| Q1 2021 | $16,000 | – | 4,240 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRUE Private Wealth Advisors | 55,500 | $64,000 | 0.01% |
| Aspire Private Capital, LLC | 1,600 | $2,000 | 0.00% |
| ROYAL BANK OF CANADA | 2,540 | $3,000 | 0.00% |
| UBS Group AG | 4,692 | $5,000 | 0.00% |
| CREDIT AGRICOLE S A | 4,240 | $5,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 200 | $0 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 13,768 | $16,000 | 0.00% |
| MORGAN STANLEY | 33,281 | $39,000 | 0.00% |
| Renaissance Technologies | 18,300 | $21,000 | 0.00% |